25.04.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehen24.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen23.04.24 | Vollzeit | Amsterdam | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen23.04.24 | Vollzeit | Wiesbaden | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen25.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHDesign. Progress. Together. CureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching
Später ansehen25.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHDesign. Progress. Together. CureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching
Später ansehen18.04.24 | Vollzeit | Wiesbaden | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen18.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen16.04.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Comber in Tübingen Landkreis kostenlos abonnieren.